Novartis' next-gen psoriasis med gets green light in Europe; Merck tests Zilmax at lower doses;

@FiercePharma: MSF urges GSK, Pfizer to slash pneumococcal vaccine prices. Report from FierceVaccines | Follow @FiercePharma

@CarlyHFierce: ICYMI: Actavis working to add Allergan CEO Pyott to board: Reuters. Story | Follow @CarlyHFierce

> The EU has approved Novartis' ($NVS) new-age psoriasis therapy, Cosentyx. More

> Merck ($MRK) is funding tests of lower Zilmax doses as it looks to reintroduce the controversial cattle feed additive to the market. Report

> Bayer has updated its Xarelto label in Europe to include guidance for use in patients with atrial fibrillation undergoing cardioversion. Release

> An ex-priest who volunteered for an early trial of Novartis' Jakavi is suing the company after suffering "catastrophic" brain damage. More

> The FDA has promoted Kathleen Uhl from acting to permanent director of its Office of Generic Drugs. More

> India's Alkem Labs has appointed banks for an IPO of up to $291 million. Report

> The FDA has released new recommendations for makers of psychoactive drugs--including sleep aids--to ensure the treatments' lingering effects don't cause car accidents. More

Medical Device News

@FierceMedDev: ICYMI: Researchers develop needle-free temporary tattoo for glucose monitoring. Article | Follow @FierceMedDev

@VarunSaxena2: Piramal buys Coldstream - The Hindu. More | Follow @VarunSaxena2

@EmilyWFierce: Carmat notches a win as artificial heart patient returns home. More | Follow @EmilyWFierce

> FDA to avoid regulating most wearables, seeking to reduce medical device regulation overall. News

> India opens medical device industry to foreign direct investment. Report

Biotech News

@FierceBiotech: ICYMI: Exclusive: Constellation chops staff, plots go-it-alone strategy as Genentech option deadline looms. Report | Follow @FierceBiotech

@JohnCFierce: Alzheimer's investigators open a new front in BACE1 war. More from FierceBiotechResearch | Follow @JohnCFierce

@DamianFierce: A CF patient taking 's Kalydeco will be a guest of Michelle Obama at the State of the Union tonight. More | Follow @DamianFierce

> Actavis, Richter tout new PhIII data for their tarnished schizophrenia drug. Article

> CytRx surges after FDA lifts a partial hold on late-stage cancer drug. Story

Biotech IT News

> Personalis raises $33M to scale up pharma-facing genomics operation. Report

> 10X Genomics exits stealth mode with $80M, plan to improve Illumina tech. News

> Novartis teams with Qualcomm on $100M digital health fund. Item

> Genentech teams with Venter's HLI as Roche group continues genomics push. Story

> 23andMe inks Pfizer deal, eyes 2015 resolution of FDA dispute. Article

CRO News

> Clinipace banks $50M to scout for more deals. Story

> Evotec strikes an R&D deal focused on addiction. More

> AMRI inks a 10-year NIH deal with $37M on the line. News

> Ergomed posts a big year with more in store for 2015. Article

> Sanofi taps Catalent for antibody R&D. Report

Animal Health News

> Annual sales of animal health products stable at $7.5B. Item

> China bans import of U.S. poultry products on avian flu fear. Report

> Microbiome dealmaking hits animal health with Metanome-Companion PBx linkup. More

> PetMed's sales fall but profit margins expand on rising demand for pricier products. Story

> Zoetis, IDEXX, Schein among animal health scene-stealers at JP Morgan confab. Article

Biotech Research News

> Genetic error highlights a new approach to Fragile X syndrome. Report

> Microbiome research opens a new pathway for autoimmune disease. Article

> Tracking tech illuminates T cells for immuno-oncology research. Item

> Michigan investigators finger ATDC gene for aggressive pancreatic cancer. Story

> Alzheimer's investigators open a new front in BACE1 war. More

Pharma Manufacturing News

> Actavis recalling 65,000 bottles of generic seizure drug. News

> FDA raises issues with another Apotex plant. Article

> India makes move to reduce reliance on Chinese APIs. Item

> Boehringer Ingelheim picks up contract work for Sanofi mAbs. News

> India's Piramal says it will snatch up university CDMO for its injectables skills. Report

And Finally... With the flu vaccine falling short this season, the U.S. death toll is rising. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.